Since the company registration one hundred and fifty-two events have happened. The last three records are Appointment of Mr Andrew Jonathan Waldron as a director on 20 February 2017; Confirmation statement made on 31 July 2016 with updates; Accounts for a dormant company made up to 31 March 2016. The most likely internet sites of IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED are www.imperialcancerresearchtechnology.co.uk, and www.imperial-cancer-research-technology.co.uk. The predicted number of employees is 1 to 10. The company’s age is forty-three years and five months. The distance to to Battersea Park Rail Station is 4.1 miles; to Brondesbury Park Rail Station is 4.5 miles; to Barnes Bridge Rail Station is 7.5 miles; to Beckenham Hill Rail Station is 8.3 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Imperial Cancer Research Technology Limited is a Private Limited Company. The company registration number is 01662284. Imperial Cancer Research Technology Limited has been working since 06 September 1982. The present status of the company is Active. The registered address of Imperial Cancer Research Technology Limited is Angel Building 407 St John Street London Ec1v 4ad. . WALDRON, Andrew Jonathan is a Secretary of the company. BLUNDY, Keith Stuart, Dr is a Director of the company. WALDRON, Andrew Jonathan is a Director of the company. Secretary CRAGGS, Madeleine Jennifer has been resigned. Secretary POINTER, Colin Leslie has been resigned. Secretary RYAN, Martin Christopher has been resigned. Secretary SCOTT, Diane Elizabeth has been resigned. Secretary STANWAY, Clive Adrian, Dr has been resigned. Secretary DLC COMPANY SERVICES LIMITED has been resigned. Director ALTHAUS, Nigel Frederick, Sir has been resigned. Director ARTUS, Ronald Edward has been resigned. Director BARNES, James David Francis, Sir has been resigned. Director BODMER, Walter, Sir has been resigned. Director CRUMPTON, Michael Joseph, Dr has been resigned. Director FORTESCUE, Seymour Henry, The Hon has been resigned. Director FOSTER, Roy William John has been resigned. Director GEE, Charles Jonathan, Dr has been resigned. Director HOUSE, William Cullingford has been resigned. Director KING, Peter David has been resigned. Director KUMAR, Harpal Singh has been resigned. Director LEE, Melanie Georgina, Doctor has been resigned. Director NEWBIGGING, David Kennedy, Sir has been resigned. Director NURSE, Paul Maxime, Sir has been resigned. Director O'GRADY, John, Professor has been resigned. Director PARKER, Peter Joseph, Professor has been resigned. Director RICHARDS, Brian Mansel, Sir has been resigned. Director ROBERTS, Derek Harry, Sir has been resigned. Director STANWAY, Clive Adrian, Dr has been resigned. Director TOOZE, John, Dr has been resigned. Director VANE, John Robert, Sir has been resigned. Director WALKER, Peter, Professor has been resigned. Director WALL, John Kenneth, Dr has been resigned. Director WRIGHT, Nicholas Alcwyn, Professor Sir has been resigned. The company operates in "Research and experimental development on biotechnology".